(Q33545587)

27 July 2017

1 reference

title

Benign prostatic hyperplasia: an overview. (English)

1 reference

27 July 2017

prostatic hypertrophy

1 reference

Ziada A

1

1 reference

27 July 2017

Rosenblum M

series ordinal

2

1 reference

27 July 2017

Crawford ED

series ordinal

3

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 March 1999

1 reference

27 July 2017

1 reference

27 July 2017

53

1 reference

27 July 2017

3 Suppl 3a

1 reference

27 July 2017

1-6

1 reference

The development of human benign prostatic hyperplasia with age

27 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900532-9

7 January 2021

Etiology and disease process of benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900532-9

7 January 2021

Epidemiology of benign prostatic hyperplasia: present knowledge and studies needed.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900532-9

7 January 2021

Correlation between liver cirrhosis and benign prostatic hyperplasia: a morphological study.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900532-9

7 January 2021

Clinical and biological characteristics of familial benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900532-9

7 January 2021

Concordance rates for benign prostatic disease among twins suggest hereditary influence

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900532-9

7 January 2021

Re: Risk factors for benign prostatic hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900532-9

7 January 2021

Is there an association between cigarette smoking and gland size in benign prostatic hyperplasia?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900532-9

7 January 2021

Influence of Age and Endocrine Factors on the Volume of Benign Prostatic Hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900532-9

7 January 2021

Changes with aging in human seminal vesicle fluid fructose concentration and seminal vesicle weight

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900532-9

7 January 2021

The importance of stroma in morphogenesis and functional activity of urogenital epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900532-9

7 January 2021

Role of peptide growth factors in the prostate: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900532-9

7 January 2021

The present role of alpha-adrenergic blockers in the treatment of benign prostatic hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900532-9

7 January 2021

Light Microscopic Stereological Analysis of the Normal Human Prostate and of Benign Prostatic Hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900532-9

7 January 2021

Autoradiographic analysis of alpha-adrenoceptors and muscarinic cholinergic receptors in the hyperplastic human prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900532-9

7 January 2021

Obstructive uropathy in the male

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900532-9

7 January 2021

Current trends in management of men with lower urinary tract symptoms and benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900532-9

7 January 2021

The pathophysiology of lower urinary tract symptoms in the ageing male population

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900532-9

7 January 2021

Adrenergic and Cholinergic Receptors in the Human Prostate, Prostatic Capsule and Bladder Neck

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900532-9

7 January 2021

Pharmacological characterization of alpha 1-adrenoceptor subtypes in the human prostate: functional and binding studies

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900532-9

7 January 2021

Bladder outlet obstruction versus impaired detrusor contractility: the role of outflow

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900532-9

7 January 2021

Pressure-flow studies of micturition

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900532-9

7 January 2021

Prostate specific antigen cannot distinguish stage T1a (A1) prostate cancer from benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900532-9

7 January 2021

Interpretation of free prostate specific antigen clinical research studies for the detection of prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900532-9

7 January 2021

Improvement of specificity in PSA-based screening by using PSA-transition zone density and percent free PSA in addition to total PSA levels

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900532-9

7 January 2021

Prostate specific antigen (PSA) value adjusted for transition zone volume and free PSA (gamma-seminoprotein)/PSA ratio in the diagnosis of prostate cancer in patients with intermediate PSA levels

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900532-9

7 January 2021

The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900532-9

7 January 2021

The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900532-9

7 January 2021

Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial. PLESS Study Group. Proscar Long-term Efficacy and Safety Stud

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900532-9

7 January 2021

Influence of finasteride on free and total serum prostate specific antigen levels in men with benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900532-9

7 January 2021

Comparative Study of Selective α1-Adrenoceptor BlockadeversusSurgery in the Treatment of Prostatic Obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900532-9

7 January 2021

Prostatic alpha 1-adrenoceptors and uroselectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900532-9

7 January 2021

Recent developments in the surgical management of benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900532-9

7 January 2021

Transurethral vaporization of the prostate: a promising new technique

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900532-9

7 January 2021

A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900532-9

7 January 2021

High-intensity focused ultrasound in the treatment of benign prostatic hyperplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900532-9

7 January 2021

10.1016/S0090-4295(98)00532-9

Identifiers

DOI

1 reference

release_uotrmr2fonho5a77aptqem3gde

27 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uotrmr2fonho5a77aptqem3gde

24 November 2022

mapped directly with Wikidata item

1 reference